COVID-19 VACCINE: COVAXIN REPORTED ADVERSE EVENT DURING PHASE 1 TRIALS

© India Today Group COVID-19 vaccine: Covaxin reported adverse event during Phase 1 trials Bharat Biotech's much-awaited COVID-19 vaccine Covaxin reported a serious adverse event during the Phase 1 clinical trials in August.  Bharat Biotech Chairman and Managing Director Dr Krishna Ella reportedly confirmed that the adverse event took place and was duly reported to the drug regulator Ce...